Breast CancerNCT00309933
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
An observational study of Breast Cancer and Cancer Survivor, run by Eastern Cooperative Oncology Group at 104 sites in United States.
Trial summary
RATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast cancer survivors. Read more about this study
- Who is it for?
- Ages 18 to 78 years, women only
- Conditions the study is for
- Breast Cancer, Cancer Survivor, Cognitive/Functional Effects
- What is being tested?
- cognitive assessment, psychosocial assessment and care and quality-of-life assessment
- Type of treatment
- Surgery or procedure
- How many people
- 2,697 participants
- Where
- 104 sitesUnited States
- Study dates
- 3 Apr 2006to Mar 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 78 years
- Women only
- No healthy volunteers
- Adult, Older adult
DISEASE CHARACTERISTICS:
- Patient
- Female breast cancer survivor with age at initial diagnosis in 1 of the following ranges:
- 18 to 45
- 55 to 78
- Must have enrolled and participated in ECOG study CLB-9741, E-1199, or E-2197
- Must have received chemotherapy at least 3 years, but no more than 8 years prior to this study entry
- Disease free at the time of this study entry
- Spouse or partner of the patient, age-matched female acquaintances of the patient (in the younger patient group), or partner of acquaintances
- Spouse or partner of the patient may be either gender
- Age-matched female acquaintance is defined as within 5 years of age difference of the patient in younger group (18-45 years of age)
- With a similar level of education and race of the patient
- Not a personal friend of the patient
- No history of breast cancer
PATIENT CHARACTERISTICS:
- Must reside in the continental U.S. and speak English (for patients)
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Trial locations and contacts
104 sites in 1 country.
104 sites in 1 country
United States104 sites
Hickman Cancer Center at Bixby Medical Center
Adrian, Michigan, 49221
McFarland Clinic, PC
Ames, Iowa, 50010
Hematology Oncology Associates of Illinois - Berwyn
Berwyn, Illinois, 60402
Suburban Hospital
Bethesda, Maryland, 20814
Wood County Oncology Center
Bowling Green, Ohio, 43402
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, 19010
Mercy Cancer Center at Mercy Medical Center
Canton, Ohio, 44708
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, 60611-3013
Hematology and Oncology Associates
Chicago, Illinois, 60611
Rush University Medical Center
Chicago, Illinois, 60612
Marshfield Clinic - Chippewa Center
Chippewa Falls, Wisconsin, 54729
MetroHealth Cancer Care Center at MetroHealth Medical Center
Cleveland, Ohio, 44109
North Coast Cancer Care - Clyde
Clyde, Ohio, 43410
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, 62526
Duluth Clinic Cancer Center - Duluth
Duluth, Minnesota, 55805-1983
CCOP - Duluth
Duluth, Minnesota, 55805
Miller - Dwan Medical Center
Duluth, Minnesota, 55805
Marshfield Clinic Cancer Care at Regional Cancer Center
Eau Claire, Wisconsin, 54701
Elkhart General Hospital
Elkhart, Indiana, 46515
Hematology Oncology Center
Elyria, Ohio, 44035
Green Bay Oncology, Limited - Escanaba
Escanaba, Michigan, 49431
Evanston Hospital
Evanston, Illinois, 60201-1781
Fredericksburg Oncology, Incorporated
Fredericksburg, Virginia, 22401
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, 54301-3526
Green Bay Oncology, Limited at St. Mary's Hospital
Green Bay, Wisconsin, 54303
St. Mary's Hospital Medical Center - Green Bay
Green Bay, Wisconsin, 54303
St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, 54307-3508
Cancer Institute of New Jersey at Hamilton
Hamilton, New Jersey, 08690
Ingalls Cancer Care Center at Ingalls Memorial Hospital
Harvey, Illinois, 60426
Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, 60521
Dickinson County Healthcare System
Iron Mountain, Michigan, 49801
Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, 32207
Mercy Regional Cancer Center
Janesville, Wisconsin, 53547
Midwest Center for Hematology/Oncology
Joliet, Illinois, 60432
Borgess Medical Center
Kalamazoo, Michigan, 49001
West Michigan Cancer Center
Kalamazoo, Michigan, 49007-3731
Bronson Methodist Hospital
Kalamazoo, Michigan, 49007
Howard Community Hospital
Kokomo, Indiana, 46904
Gundersen Lutheran Center for Cancer and Blood
La Crosse, Wisconsin, 54601
Center for Cancer Therapy at LaPorte Hospital and Health Services
La Porte, Indiana, 46350
Clarian Arnett Cancer Care
Lafayette, Indiana, 47904
Haematology-Oncology Associates of Ohio and Michigan, PC
Lambertville, Michigan, 48144
Lancaster General Hospital
Lancaster, Pennsylvania, 17604
North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville, Illinois, 60048
Lima Memorial Hospital
Lima, Ohio, 45804
Manchester Memorial Hospital
Manchester, Connecticut, 06040
Bay Area Cancer Care Center at Bay Area Medical Center
Marinette, Wisconsin, 54143
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
Marlton, New Jersey, 08053
Marshfield Clinic - Marshfield Center
Marshfield, Wisconsin, 54449
Northwest Ohio Oncology Center
Maumee, Ohio, 43537-1839
St. Luke's Hospital
Maumee, Ohio, 43537
Marshfield Clinic - Lakeland Center
Minocqua, Wisconsin, 54548
Community Cancer Center of Monroe
Monroe, Michigan, 48162
Mercy Memorial Hospital - Monroe
Monroe, Michigan, 48162
Community Hospital of the Monterey Peninsula Comprehensive Cancer Center
Monterey, California, 93940
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Morgantown, West Virginia, 26506
La Grange Oncology Associates - Geneva
Naperville, Illinois, 60563
MBCCOP - Meharry Medical College - Nashville
Nashville, Tennessee, 37208-3599
Jersey Shore Cancer Center at Jersey Shore University Medical Center
Neptune City, New Jersey, 07754-0397
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08903
Cancer Care and Hematology Specialists of Chicagoland - Niles
Niles, Illinois, 60714
Regional Cancer Center at Oconomowoc Memorial Hospital
Oconomowoc, Wisconsin, 53066
Green Bay Oncology, Limited - Oconto Falls
Oconto Falls, Wisconsin, 54154
St. Charles Mercy Hospital
Oregon, Ohio, 43616
Toledo Clinic - Oregon
Oregon, Ohio, 43616
Cancer Center of Paoli Memorial Hospital
Paoli, Pennsylvania, 19301-1792
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, 19111-2497
Cancer Center at Phoenixville Hospital
Phoenixville, Pennsylvania, 19460
Ministry Medical Group at Saint Mary's Hospital
Rhinelander, Wisconsin, 54501
Marshfield Clinic - Indianhead Center
Rice Lake, Wisconsin, 54868
Lakeland Regional Cancer Care Center - St. Joseph
Saint Joseph, Michigan, 49085
North Coast Cancer Care, Incorporated
Sandusky, Ohio, 44870
Guthrie Cancer Center at Guthrie Clinic Sayre
Sayre, Pennsylvania, 18840
Siouxland Hematology-Oncology Associates, LLP
Sioux City, Iowa, 51101
Mercy Medical Center - Sioux City
Sioux City, Iowa, 51104
St. Luke's Regional Medical Center
Sioux City, Iowa, 51104
Medical X-Ray Center, PC
Sioux Falls, South Dakota, 57105
Sanford Cancer Center at Sanford USD Medical Center
Sioux Falls, South Dakota, 57117-5039
Hematology Oncology Associates - Skokie
Skokie, Illinois, 60076
CCOP - Northern Indiana CR Consortium
South Bend, Indiana, 46601
Memorial Hospital of South Bend
South Bend, Indiana, 46601
Saint Joseph Regional Medical Center
South Bend, Indiana, 46617
South Bend Clinic
South Bend, Indiana, 46617
Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, 62781-0001
Marshfield Clinic at Saint Michael's Hospital
Stevens Point, Wisconsin, 54481
Green Bay Oncology, Limited - Sturgeon Bay
Sturgeon Bay, Wisconsin, 54235
Flower Hospital Cancer Center
Sylvania, Ohio, 43560
CCOP - Scott and White Hospital
Temple, Texas, 76508
Mercy Hospital of Tiffin
Tiffin, Ohio, 44883
Toledo Hospital
Toledo, Ohio, 43606
St. Vincent Mercy Medical Center
Toledo, Ohio, 43608
Medical University of Ohio Cancer Center
Toledo, Ohio, 43614
CCOP - Toledo Community Hospital
Toledo, Ohio, 43617
St. Anne Mercy Hospital
Toledo, Ohio, 43623
Toledo Clinic, Incorporated - Main Clinic
Toledo, Ohio, 43623
Fox Chase Virtua Health Cancer Program at Virtua West Jersey
Voorhees Township, New Jersey, 08043
Waukesha Memorial Hospital Regional Cancer Center
Waukesha, Wisconsin, 53188
Marshfield Clinic - Wausau Center
Wausau, Wisconsin, 54401
Fulton County Health Center
Wauseon, Ohio, 43567
Marshfield Clinic - Weston Center
Weston, Wisconsin, 54476
Marshfield Clinic - Wisconsin Rapids Center
Wisconsin Rapids, Wisconsin, 54494
CCOP - Main Line Health
Wynnewood, Pennsylvania, 19096
Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania, 19096
York Hospital's Oncology Treatment Center
York Village, Maine, 03909
About this study
Official title: Quality of Life in Younger Breast Cancer Survivors
RATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast cancer survivors.
PURPOSE: This clinical trial is studying quality of life in female breast cancer survivors and their spouse, partner, or acquaintance.
Read the detailed description
OBJECTIVES:
- Compare the quality of life (physical functioning, psychological functioning, social functioning, and spiritual functioning) of female breast cancer survivors who were age 45 or younger at the time of diagnosis with the quality of life of female breast cancer survivors who were age 55 to 70 at time of diagnosis (considering type of surgical treatment [lumpectomy vs mastectomy], hormonal treatments, and time since diagnosis as covariates) and age-matched (to the younger group) females with no history of breast cancer.
- Compare the quality of life (physical functioning, psychological functioning, social functioning, and spiritual functioning) of partners of breast cancer survivors who were age 45 or younger at time of diagnosis with the quality of life of partners of breast cancer survivors who were age 55 to 70 at diagnosis and partners of age-matched (to the younger group) females with no history of breast cancer.
- Test and compare quality of life models that identify the variables that mediate between antecedent variables of personal characteristics, diagnostic and treatment characteristics, and quality of life outcomes in order to determine where interventions to improve quality of life should be targeted.
- Explore the relationship of partner antecedent, mediating, and outcome variables as predictors or mediators of outcome variables for breast cancer survivors.
OUTLINE: This is a multicenter study.
Patients, spouse or partner of patients, age-matched acquaintances of patients, and partner of acquaintances complete questionnaires over 60-90 minutes about personal characteristics, self-efficacy, coping, social support, health care provider communication, physical, psychological, social, and spiritual functioning, and quality of life. After completing the study questionnaires, patients and age-matched acquaintances of patients are interviewed via telephone over 30 minutes for cognitive function assessment. A random subset of patients and spouses/partners of patients are interviewed via telephone over 45-60 minutes, using data-generating and open-ended questions, regarding physical functioning, sexual and reproductive issues, psychological issues, social impact, and methods used to deal with breast cancer survivor concerns.
Disease and treatment characteristics of patients are obtained from medical records.
PROJECTED ACCRUAL: A total of 2,697 patients, spouse or partner of patients, age-matched female acquaintances of patients, and partner of acquaintances will be accrued for this study.
- Conditions
- Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
- Being tested
- cognitive assessment, psychosocial assessment and care, quality-of-life assessment
- Keywords
- cognitive/functional effects, spiritual concerns, sexuality and reproductive issues, psychosocial effects of cancer and its treatment, cancer survivor, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer
- Medical subject headings
- Breast Neoplasms, Sexuality
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cognitive assessmentProcedure or surgery
psychosocial assessment and careProcedure or surgery
quality-of-life assessmentProcedure or surgery
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of the quality of life
Comparison of the quality of life of partners
Comparison of quality of life models
Correlation between partner antecedent, mediating, and outcome variables with patient outcome variables
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2006 (estimated)
- Study start3 Apr 2006
- Primary completionMar 2011
- Study completionMar 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Enrolment
- 2,697 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Eastern Cooperative Oncology Group
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Victoria Champion, DNS, Study chair, Indiana UniversityGeorge W. Sledge, MD, Indiana UniversityLynne Wagner, MD, Robert H. Lurie Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00309933
- Sponsor's protocol ID
- CDR0000460234
- Other IDs
- ECOG-E2Z04
- Status last verified
- Jun 2023
- First submitted
- 29 Mar 2006
- Last updated
- 18 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Quality of Life in Younger Breast Cancer Survivors
- ClinicalTrials.gov ID
- NCT00309933
- Acronym / sponsor ID
- CDR0000460234
- Conditions
- Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
- Keywords
- cognitive/functional effects, spiritual concerns, sexuality and reproductive issues, psychosocial effects of cancer and its treatment, cancer survivor, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,697 participants (estimated)
- Lead sponsor
- Eastern Cooperative Oncology GroupResearch network
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 3 Apr 2006 (actual)
- Primary completion
- Mar 2011 (actual)
- Study completion
- Mar 2011 (actual)
- First posted
- 3 Apr 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Studying quality of life in breast cancer survivors may help determine the long-term effects of breast cancer and may help improve the quality of life for future breast cancer survivors.
PURPOSE: This clinical trial is studying quality of life in female breast cancer survivors and their spouse, partner, or acquaintance.
Detailed description
OBJECTIVES:
- Compare the quality of life (physical functioning, psychological functioning, social functioning, and spiritual functioning) of female breast cancer survivors who were age 45 or younger at the time of diagnosis with the quality of life of female breast cancer survivors who were age 55 to 70 at time of diagnosis (considering type of surgical treatment [lumpectomy vs mastectomy], hormonal treatments, and time since diagnosis as covariates) and age-matched (to the younger group) females with no history of breast cancer.
- Compare the quality of life (physical functioning, psychological functioning, social functioning, and spiritual functioning) of partners of breast cancer survivors who were age 45 or younger at time of diagnosis with the quality of life of partners of breast cancer survivors who were age 55 to 70 at diagnosis and partners of age-matched (to the younger group) females with no history of breast cancer.
- Test and compare quality of life models that identify the variables that mediate between antecedent variables of personal characteristics, diagnostic and treatment characteristics, and quality of life outcomes in order to determine where interventions to improve quality of life should be targeted.
- Explore the relationship of partner antecedent, mediating, and outcome variables as predictors or mediators of outcome variables for breast cancer survivors.
OUTLINE: This is a multicenter study.
Patients, spouse or partner of patients, age-matched acquaintances of patients, and partner of acquaintances complete questionnaires over 60-90 minutes about personal characteristics, self-efficacy, coping, social support, health care provider communication, physical, psychological, social, and spiritual functioning, and quality of life. After completing the study questionnaires, patients and age-matched acquaintances of patients are interviewed via telephone over 30 minutes for cognitive function assessment. A random subset of patients and spouses/partners of patients are interviewed via telephone over 45-60 minutes, using data-generating and open-ended questions, regarding physical functioning, sexual and reproductive issues, psychological issues, social impact, and methods used to deal with breast cancer survivor concerns.
Disease and treatment characteristics of patients are obtained from medical records.
PROJECTED ACCRUAL: A total of 2,697 patients, spouse or partner of patients, age-matched female acquaintances of patients, and partner of acquaintances will be accrued for this study.
Study design
Who may qualify
- Ages
- 18 to 78 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cognitive assessment | Procedure or surgery | – |
| psychosocial assessment and care | Procedure or surgery | – |
| quality-of-life assessment | Procedure or surgery | – |
Primary outcome
Comparison of the quality of life
Comparison of the quality of life of partners
Comparison of quality of life models
Correlation between partner antecedent, mediating, and outcome variables with patient outcome variables
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2023.
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Victoria Champion, DNS study chair
Indiana University
George W. Sledge, MD
Indiana University
Lynne Wagner, MD
Robert H. Lurie Cancer Center
104 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Breast Cancer and Cancer Survivor, run by Eastern Cooperative Oncology Group at 104 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 104 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of the quality of life. The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2023; AzTrials last refreshed its copy on 8 Nov 2026.